Mechanism: Circulating low-molecular-weight hyaluronan (LMW-HA) from aged skin activates intestinal TLR4, causing gut leakiness and vagal afferent activation, which drives neuroinflammation. Readout: Readout: Oral high-molecular-weight hyaluronan (HMW-HA) or a TLR4 antagonist reduces gut permeability, shifts microbiome composition, dampens vagal signaling, decreases neuroinflammation, and extends lifespan.
Hypothesis
Age‑related decline of HAS2 in dermal fibroblasts shifts the hyaluronan (HA) balance toward circulating low‑molecular‑weight HA (LMW‑HA) fragments. These fragments act as systemic danger‑associated molecular patterns (DAMPs) that directly remodel the gut‑brain axis by:
- Binding TLR4 on intestinal epithelial cells (IECs) → NF‑κB‑mediated inflammation → increased tight‑junction permeability (↑ zonulin, ↓ claudin‑1).
- Facilitating bacterial translocation (e.g., LPS) into the lamina propria, which further stimulates IEC‑derived cytokines and activates TLR4 on vagal afferent nodose ganglia.
- Being hydrolyzed by bacterial hyaluronidases into HA oligosaccharides that selectively enrich pro‑inflammatory taxa (e.g., Enterobacteriaceae) while depleting mucin‑degrading symbionts (e.g., Akkermansia).
- Creating a feed‑forward loop: vagal afferent signaling to the nucleus tractus solitarius amplifies central microglial activation, which in turn promotes systemic inflammaging and further fibroblast senescence.
Thus, circulating LMW‑HA is not merely a skin‑localized DAMP but a systemic signal that converts the gut microbiome from a homeostatic partner into an inflammagenic driver of neuroinflammation.
Mechanistic Rationale Beyond Cited Work
- While naked mole‑rat HMW‑HA preserves intestinal stem cells, the converse effect of LMW‑HA on IEC TLR4 has not been tested in aged mammals. TLR4 expression on IECs is known to rise with age, making them primed to respond to LMW‑HA.
- Vagal afferents express TLR4 and can be activated by LPS; LMW‑HA‑induced IEC leakiness provides a plausible route for luminal LPS to reach these neurons without requiring direct HA‑vagal binding.
- Microbial hyaluronidases (e.g., from Streptococcus spp.) are upregulated in dysbiotic microbiomes and generate HA oligosaccharides that can act as chemokines for immune cells, a link absent from current HA‑aging literature.
- The hypothesis integrates three layers—extracellular matrix aging, gut barrier immunity, and neural signaling—offering a systems‑level explanation for why inflammaging correlates with both skin phenotypes and cognitive decline.
Testable Predictions
- Correlation: In aged mice (≥24 mo), serum LMW‑HA levels will positively correlate with gut permeability markers (FITC‑dextran assay, serum zonulin) and colonic LPS content.
- Microbiome Shift: 16S rRNA sequencing will show enrichment of Proteobacteria (especially Enterobacteriaceae) and depletion of Akkermansia in high‑LMW‑HA mice compared to age‑matched controls.
- Vagal Activation: Electrophysiological recordings of the cervical vagus will reveal increased firing rates in response to intraperitoneal LMW‑HA administration, an effect abolished by IEC‑specific TLR4 knockout.
- Neuroinflammation: Immunohistochemistry for Iba1 and phospho‑p65 in the hippocampus will be elevated in high‑LMW‑HA mice and reduced by vagal transection or gut‑restricted TLR4 antagonism.
- Rescue: Oral supplementation with HMW‑HA (≥2 MDa) or a gut‑restricted TLR4 antagonist (e.g., TAK‑242) will normalize permeability, microbiome composition, vagal firing, and microglial activation despite persistent dermal fibroblast senescence.
Falsifiability
If any of the following are observed, the hypothesis is refuted:
- Serum LMW‑HA does not predict gut permeability or microbial shifts in aged animals.
- IEC‑specific TLR4 deletion fails to attenuate LMW‑HA‑induced permeability or vagal activation.
- Vagotomy or TLR4 blockade on vagal afferents does not reduce central microglial activation despite unchanged gut leakiness.
- HMW‑HA supplementation does not rescue any of the phenotypes.
Experimental Outline (brief)
- Groups: Young (3 mo) vs. aged (24 mo) wild‑type; aged IEC‑TLR4 KO; aged vagal‑TLR4 KO; aged + oral HMW‑HA; aged + gut‑restricted TAK‑242.
- Measurements: Serum HMW‑HA/LMW‑HA (ELISA), FITC‑dextran permeability, colonic LPS (LAL assay), 16S rRNA sequencing, vagal electrophysiology, hippocampal Iba1/p‑p65, behavior (novel object recognition).
- Analysis: Two‑way ANOVA with post‑hoc Tukey; correlation Pearson r; mediation analysis to test whether permeability mediates the LMW‑HA → neuroinflammation link.
By directly linking dermal fibroblast senescence to gut barrier disruption, microbial dysbiosis, and vagal‑mediated neuroinflammation, this hypothesis transforms an ignored "messy" axis into a measurable, actionable circuit driving age‑related systemic inflammation.
Comments
Sign in to comment.